On June 21st, 2018, the signing ceremony of strategic cooperation with Tian Ma Bird Nest Sdn Bhd was held in Zhonghua Southern Pharma Sdn Bhd. Mr. Bai Xianfeng, president of Southern Pharma and Dato’ Paduka Beh Heng Seong, chief director of the collaborating party Beh Heng Seong Sdn Bhd were present. Southern Pharma will hold 70% of Tian Ma’s shares through capital increase and share enlargement while Beh Heng Seong 30%. The two parties will work collectively to build the bird’s nest brand Tian Ma and explore the market both at home and abroad.
Mr. Bai Xianfeng and Dato’ Paduka Beh Heng Seong delivered speeches respectively, exchanged opinions on R&D, quality control and marketing of edible bird’s nest and made strategic plan for future development.
Tian Ma Bird Nest is one of the first 8 manufactures approved by the Malaysian government to export to China and owns all the necessary qualifications. CCTV finance and economics channel has make special report about it as the representative of Malaysian edible bird’s nest companies because of its high quality of products and good company image.
Under the Belt and Road Initiative, Southern Pharma is building itself as a model company according to the internationalization strategy of Sinopharm Group and Sinopharm TCM. This strategic cooperation is an essential step towards the “big Southern Pharma” health industry. It will also serve as a platform for China-Malaysia cooperation and lay a solid foundation for the development in TCM. (Reported by Sinopharm TCM)